COVID Response

Inflection Technologies’ president contributes to worldwide COVID response through research that helped the US and world understand that low-risk individuals could maintain largely normal outdoor access while improving indoor ventilation to minimize indoor risk and maximize business productivity. The research in 2020 can be found on medRxiv. Links to this research became widely public in the New York Times, Wall Street Journal, SFGate, and other worldwide news in 2021, and acknowledged by the CDC in March 2022.

“The estimates herein may help efforts to strike a balance in developing holistic epidemiologic interventions that consider the effects of these interventions on economic, civic, social, and mental health, which have pathologies within their own realms.”

PDF Version